ethyl 4-(cyclopropylamino)-2-(methylthio)pyrimidine-5-carboxylate, 98%, 1g

[3-(1-Phenyl-cyclobutyl)-[1,2,4]oxadiazol-5-ylmethyl]-carbamic acid tert-butyl ester, 95.0%, 1g

N-Cyclohexylethanolamine>98.0%(T)25g

(1R,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate, 95.0%, 25g

Iberdomide, 50mg

Chloro[[1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene](N,N-dimethylbenzylamine)palladium(II)]>97.0%(T)1g

(R)-3-Amino-3-(2-chlorophenyl)propanoic acid, 97%, 5g

2-Ethyl-1-hexanol>99.5%(GC)25mL

Methyl 4,5-difluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 97%, 5g

2,3-Dibromo-2,3-dimethylbutane, 97%, 10g

N-Lauroyl-L-lysine, 95.0%, 100mg

1,3,5-Tris(bromomethyl)-2,4,6-trimethylbenzene, 95.0%, 25g

(S)-2-amino-2-(3,5-dichlorophenyl)ethan-1-ol, 98%, 250mg